AAAAAA
Results:
1-11
|
Results: 11
Authors:
Carrieri, P
Cailleton, V
Le Moing, V
Spire, B
Dellamonica, P
Bouvet, E
Raffi, F
Journot, V
Moatti, JP
Citation: P. Carrieri et al., The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort, J ACQ IMM D, 28(3), 2001, pp. 232-239
Authors:
Pradier, C
Carrieri, P
Bentz, L
Spire, B
Dellamonica, P
Moreau, J
Moatti, JP
Citation: C. Pradier et al., Impact of short-term adherence on virological and immunological success ofHAART: a case study among French HIV-infected IDUs, INT J STD A, 12(5), 2001, pp. 324-328
Authors:
Duran, S
Solas, C
Spire, B
Carrieri, MP
Fuzibet, JG
Costagliola, D
Lacarelle, B
Moatti, JP
Citation: S. Duran et al., 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports andserum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, 15(8), 2001, pp. 1075-1077
Authors:
Moatti, JP
Spire, B
Duran, S
Citation: Jp. Moatti et al., A review of socio-behavioural studies on adherence to antiretroviral treatments: beyond biomedical models?, REV EPIDEM, 48(2), 2000, pp. 182-197
Authors:
Carrieri, MP
Vlahov, D
Dellamonica, P
Gallais, H
Lepeu, G
Spire, B
Obadia, Y
Citation: Mp. Carrieri et al., Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART, DRUG AL DEP, 60(1), 2000, pp. 51-54
Authors:
Moatti, JP
Carrieri, MP
Spire, B
Gastaut, JA
Cassuto, JP
Moreau, J
Citation: Jp. Moatti et al., Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment, AIDS, 14(2), 2000, pp. 151-155
Authors:
Moatti, JP
Spire, B
Citation: Jp. Moatti et B. Spire, Living with HIV/AIDS and adherence to antiretroviral treatments, SOC AS AIDS, 2000, pp. 57-73
Authors:
Cosma, A
Blanc, D
Braun, J
Quillent, C
Barassi, C
Moog, C
Klasen, S
Spire, B
Scarlatti, G
Pesenti, E
Siccardi, AG
Beretta, A
Citation: A. Cosma et al., Enhanced HIV infectivity and changes in GP120 conformation associated withviral incorporation of human leucocyte antigen class I molecules, AIDS, 13(15), 1999, pp. 2033-2042
Authors:
Spire, B
Souville, M
Citation: B. Spire et M. Souville, Drug-resistant genotyping in HIV-1 therapy, LANCET, 354(9184), 1999, pp. 1121-1121
Authors:
Agostini, I
Navarro, JM
Bouhamdan, M
Willetts, K
Rey, F
Spire, B
Vigne, R
Pomerantz, R
Sire, J
Citation: I. Agostini et al., The HIV-1 Vpr co-activator induces a conformational change in TFIIB, FEBS LETTER, 450(3), 1999, pp. 235-239
Authors:
Purgus, R
Tamalet, C
Poignard, P
Spire, B
George, F
Robert, A
Olmer, M
Citation: R. Purgus et al., Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient, TRANSPLANT, 66(10), 1998, pp. 1384-1386
Risultati:
1-11
|